The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
For Health Care Providers
How can providers prescribe COVID-19 therapeutics to patients?
Clinicians caring for COVID-19 patients should be aware of the availability of these important life-saving medications and consider use when clinically indicated. When prescribing COVID-19 treatments, health care providers can use the following tools:
For an overview of mild to moderate COVID-19 outpatient therapies:
- Therapeutic Management of Nonhospitalized Adults with COVID-19
- COVID-19 Therapeutics Education Session for Clinicians
For the management of Paxlovid drug-drug-interactions:
- Paxlovid Drug-Drug-Interactions list by University of Michigan
- COVID-19 Drug interactions by University of Liverpool
- Paxlovid Patient Eligibility Screening Checklist Tool for Prescribers
To see what locations currently have COVID-19 therapeutics.
What is Test to Treat?
The Test to Treat program is a nationwide initiative launched by the federal government to ensure rapid access to no-cost COVID-19 oral medications for individuals who have tested positive for COVID–19, who are experiencing mild to moderate symptoms, and who are at high risk for severe disease including hospitalization and/or death. Test to Treat sites will provide COVID-19 tests, determine eligibility of COVID-19 patients to receive COVID-19 therapy, and prescribe medication that patients can fill on-site or at affiliated pharmacies.
Billing and Coding
During times of limited availability of therapeutic mediations, it is essential that all prescribers apply ethical principles in determining eligibility of these medications. Medications should only be prescribed in bonified clinician-patient relationships. Additional information on ethical principles during scarce resource allocations can be obtained through MDHHS.